Personal Lubricant Market Size Worth $1.6 Billion By 2026

The global personal lubricant market size is expected to reach USD 1.6 billion by 2026, based on a new report by Grand View Research, Inc., exhibiting a CAGR of 8.1%. New product launches to meet demand for natural lubricants is expected to aid market growth over the forecast period.

Emerging players are trying to capture higher share by developing lubricants made from natural and organic ingredients. Good Clean Love, Inc., an Oregon-based company in the U.S., was the first to develop organic lubricants. In November 2016, the company received a patent for its formulation of organic lubricants.

Moreover, promotional activities from manufacturers to destigmatize societal perception of using personal lubricants has positively impacted growth. For instance, in January 2019, Reckitt Benckiser’s Durex brand launched a marketing campaign on a global platform to challenge the misconceptions of using lubricants for female sexual discomfort.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/personal-lubricant-market

Further key findings from the study suggest:

Water-based lubricants dominated the market in 2018, owing to lower prices and as they are easy to wash off
Leading brands such as Durex, Sliquid, and Astroglide retail a range of water-based lubricants with variations in flavors, pack size, and packaging
In July 2018, Trigg Laboratories, Inc. reinvented its entire product line with new packaging and products, which had contemporary, sleek, and modern designs. It also launched a new product line—Wet Hemptation and Wet Dessert
The growing presence of e-commerce platforms and online retailers that offer freedom to select any product and make discrete delivery has helped overcome social taboo of buying these products
Manufacturers, retail pharmacies, and supermarkets have also launched websites for providing easy access to customers.
Geographically, North America held the largest share in 2018. The personal lubricant market is regulated by the U.S. FDA and manufacturers must comply with good manufacturing practices, and receive 510(k) medical device clearance for marketing
In May 2016, Trigg Laboratories received FDA approval for Wet Original Personal lubricant by meeting the provisions for labeling, good manufacturing practices and prohibitions against adulteration and misbranding
According to U.S. Census data and National Consumer survey, in 2018, K-Y lubricants were used by 28.58 million people, aiding it to capture significant share in the U.S.
Asia Pacific is expected to be the fastest growing market during the forecast period. Aging population and high incidence of vaginal dryness & erectile are anticipated to drive demand.

Advanced Bipolar Direct Energy Devices Market Worth $3.3 Billion By 2026

The global advanced bipolar direct energy devices market size is anticipated to reach USD 3.3 billion by 2026 registering a CAGR of 14.2%, according to a new report by Grand View Research, Inc. Increasing adoption of bipolar electrosurgical systems over conventional devices and high demand for laparoscopic surgeries are anticipated to boost the market growth.

These systems are mostly used to coagulate, cutting, fulguration, and desiccate soft tissues through generating heat by an electric current. The product demand has been increasing owing to its benefits in surgical procedures, such as lower risk of hemorrhaging than conventional devices that focus on scalpels. In addition, conventional equipment are costlier, which is also driving the demand for advanced bipolar direct energy systems for improved safety in desiccating soft tissues.

Technological advancements in the field are further expected to augment the market growth. For instance, XCELLANCE Medical Technologies launched a new 6-sense technology designed for cutting tissues at lower voltages by sensing voltage and power. This technology minimizes the patient recovery time and is a versatile tool for hemostatic dissection in performing surgical procedure.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/advanced-bipolar-direct-energy-devices-market

Further key findings from the report suggest:

Electrosurgical generator systems led the global market in 2018. The segment is projected to expand further at the fastest CAGR from 2019 to 2026
Hospital was the dominant end use segment in 2018 owing to increased number of laparoscopic surgical procedures for tissue coagulation performed in these healthcare settings
North America led the global advanced bipolar direct energy devices market in 2018. However, Asia Pacific is estimated to be the fastest-growing regional market over the forecast period
Some of the key companies in this market are Bovie Medical Corp., Medtronic PLC, B. Braun Melsungen AG, XCELLANCE Medical Technologies Pvt. Ltd., Olympus Corp., and Karl Storz
These companies focus on technological advancements to gain competitive advantage. Medtronic launched Aquamantys bipolar sealers designed by transcollation technology, which combines Radiofrequency (RF) energy and saline to provide hemostatic sealing of soft tissues

Scleroderma Therapeutics Market Size Worth $2.6 Billion By 2026

The global scleroderma therapeutics market size is expected to reach over USD 2.6 billion by 2026 registering a CAGR of 6.0%, according to a new study by Grand View Research, Inc. The market growth is credited to the availability of various therapies used off-label, such as small molecule therapies including branded, generics, and OTC drugs.

The mix of several indications and drug classes engenders a fragmented market with multiple players. Roche is the dominant company with biologic immunosuppressants, Actemra/RoActemra, Cellcept, and Rituxan contributing majorly to the company’s share. Pfizer and Eli Lilly are the key companies in the market. Over the forecast period, new entrants including Boehringer Ingelheim, Corbus Pharmaceuticals, and Fibrocell will marginally displace the share of established firms in this market.

The on-label market is in the development phase. Supplemental indication approval is one of the most common strategies adopted by market participants. For example, riociguat by Bayer was previously used for PAH and currently, it is under clinical trials for the treatment of SSc-related digital ulcers. There are several other pharmaceutical companies following suit as this strategy favors the pharmaceutical industry in offsetting high development costs and in reaping larger benefits from one molecule already developed and present in the market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/scleroderma-therapeutics-market

Further key findings from the study suggest:

The immunosuppressants segment held the largest market share in 2018 and is likely to maintain the dominance throughout the forecast years
High preference for immunosuppressants owing to the favorable reimbursement scenario associated with this drug class supports its dominant market share
Systemic scleroderma indication segment accounted for the major market share and will expand further due to use of high-priced immunosuppressants
U.S. held the majority of the share in 2018. Expected label expansions and expected launch of first-in-class therapies coupled with an evolving reimbursement landscape for orphan drugs support continual scleroderma therapeutics market growth
Europe trails with a lower share as compared to the U.S. majorly due to higher use of generics and biosimilars for off-label treatment of scleroderma
Some of the key companies are F. Hoffman La-Roche Ltd.; Bristol-Myers Squibb Company; Celgene Corp.; arGentis Pharmaceuticals, LLC; Bayer AG; Boehringer Ingelheim International GmbH; Akashi Therapeutics; Prometic Life Sciences, Inc.; Emerald Health Pharmaceuticals; Kadmon Holdings, Inc.; Seattle Genetics, Inc.; Cytori Therapeutics, Inc.; Fibrocell Science, Inc.; Chemomab; Corbus Pharmaceuticals Holdings, Inc.; and Genkyotex SA

Oral Irrigator Market Size Worth $1.1 Billion By 2026

The global oral irrigator market size is expected to reach USD 1.1 billion by 2026, according to a new report by Grand View Research, Inc., registering a 3.4% CAGR during the forecast period. Introduction of technologically advanced dental care products and growing incidence of oral diseases, such as dental caries and periodontitis, are majorly driving the market.

Easy availability of oral irrigators for end users like dentists and consumers is one of the drivers of the global oral irrigator market. These are available through various online portals such as Amazon, eBay, and AliExpress, and medical stores.

Initiatives by various dental organizations and agencies, especially in developing countries such as India, are significantly impacting market growth. In India, agencies such as eDantSeva, National Tobacco Control Programme (NTCP) and National Institute of Cancer Prevention and Research (NICPR) conduct programs for increasing awareness regarding dental hygiene and habits, further propelling the market.

Oral irrigators are expensive as compared to traditional floss products, which is hampering oral irrigator market growth. Nonetheless, value benefits offered by manufacturers for the promotion of technologically advanced products, along with increasing pricing competition, is estimated to lower the impact of high costs and increase its popularity among consumers. This is likely to help shift individual preference from tradition flossing methods to using efficient oral irrigators.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/oral-irrigator-market

Further key findings from the study suggest:

Cordless product variants formed the leading segment owing to features such as safety, portability, and reasonably priced. The countertop segment is also likely to witness steady growth owing to convenience as they do not require charging like cordless devices
Product adoption for home use has been on a rise owing to increasing popularity of technologically advanced products and growing awareness regarding benefits of regular flossing and good dental hygiene
Increasing prevalence of teeth and gum disorders on a global scale, rise in population in developing economies, and increase in spending power of consumers are anticipated to majorly drive the oral irrigator market
Some of the key players in the market are Church & Dwight Co., Procter & Gamble, Jetpik, Aquapick, and Conair Corporation.

Wound Care Market Size Worth $25.1 Billion By 2026

The global wound care market size is expected to reach USD 25.1 billion by 2026, according to a new report by Grand View Research, Inc., registering a 3.9% CAGR during the forecast period. Increase in prevalence of chronic diseases globally, rising number of ambulatory surgical centers (ASCs), and growing geriatric population are key factors driving the global market.

ASCs offer a variety of services such as surgical assistance, diagnostics, and preventive procedures. Surgeries for pain management, urology, orthopedics, restorative, and gastro intestinal (GI) conditions are also performed in ambulatory surgery centers. Earlier, ASCs were only capable of performing GI-related minor surgeries; however, with increase in number of minimally invasive surgical procedures, services offered by ambulatory surgical centers have expanded and grown exponentially.

According to the U.S. Department of Health and Human Services (HHS) data records of 2014, there were 17.2 million hospital visits. These included invasive, therapeutic surgeries, and ambulatory surgeries. Around 9.94 million (57.8%) of these surgeries occurred in hospital-owned ambulatory surgery settings and the remaining 7.26 million surgeries (42.2%) were conducted in hospitals. ASCs are increasing in number and thus offer cost-effective services. In addition, favorable reimbursement coverages are being provided with regard to services provided by ASCs. The chances of contracting post-surgical, hospital-related infections are also reduced. ASCs provide specific instructions to patients regarding post-surgical homecare. Thus, with an increase in the number of ASCs and number of surgical procedures, demand for wound care is expected to increase.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/wound-care-market

Further key findings from the report suggest:

In terms of revenue, the advanced dressing segment held the largest share in 2018 owing to increasing cases of chronic diseases and rising adoption of advanced wound care products across the globe
The home healthcare segment is expected to witness the fastest growth over the forecast period due to increasing geriatric population and rising adoption of negative pressure wound therapy
On the basis of application, the acute segment held the largest wound care market share in 2018 owing to rising number of surgeries and burn cases across the globe
Asia Pacific is expected to witness the fastest growth over the forecast period owing to increasing number of surgeries and rising cases of burns in this region
Prominent key players present in the wound care market include Smith and Nephew; Molnlycke Health Care AB; and Baxter International Inc.

Breast Reconstruction Market Worth $3.8 Billion By 2026

The global breast reconstruction market size is expected to reach USD 3.8 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 6.9% during the forecast period. Rising prevalence of breast cancer, cases of breast reconstruction procedures, and introduction of technologically advanced products are the key driving factors for the growth.

Increasing incidence of breast cancer across the globe is one of the key driving factors for the market growth. According to the Breast Cancer Research Foundation (BCRF), breast cancer is considered as the most common type of cancer among American women after skin cancer. Such high incidence in U.S. has resulted in an increased number of mastectomy and lumpectomy procedures, which boosts the demand for breast implants and tissue expanders.

According to the American Cancer Society, Cancer Facts & Figures 2015, BCRF also estimated that over 40,290 women may die due to breast cancer. Prevention of breast cancer involves mastectomy, which requires removal of the entire organ. Breast reconstruction helps restore the shape of the breast, thereby enhancing the quality of a patient’s life. It basically involves rebuilding the shape of the removed breast. Thus, high prevalence of breast cancer and growing number of mastectomies are the major factors anticipated to drive the demand for breast reconstruction procedures, thereby propelling the market growth over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/breast-reconstruction-market

Further key findings from the report suggest:

In terms of revenue, breast implants segment held the largest market share in 2018 and is expected to witness the fastest CAGR over the forecast period owing to the rising consciousness towards physical appearance and increasing disposable income in the developed and developing countries
Anatomical breast implants is expected to witness the fastest CAGR over the forecast period owing to the increasing incidence of breast cancer across the globe
Hospital segment held the largest market share in 2018 due to the rising cases of breast reconstruction surgeries
Asia Pacific breast reconstruction market is expected to witness the fastest CAGR over the forecast period owing to the rising number of surgical procedures in this region
Prominent market players are Mentor Worldwide LLC; Allergan Inc.; Sientra, Inc.; Ideal Implant Incorporated; Establishment Labs S.A.; and POLYTECH Health & Aesthetics GmbH

Transcranial Magnetic Stimulator Market Worth USD 1,732.11 Million By 2026

The global transcranial magnetic stimulator market is anticipated to reach USD 1,732.11 million by 2026, according to a new report by Grand View Research, Inc. Increasing incidence of psychological and neurological disorder such as major depressive disorder is anticipated to boost the market growth.

Increasing number of patients suffering from depression and other neurological disorder are driving the market growth. For instance, according to the National Institute of Mental Health (NIMH), around 17.3 million people in the U.S. have at least one major depressive disorder. Other neurological disorder such as schizophrenia which is a severe mental disorder start between the ages of 16-30 years. According to National Institute of Mental Health (NIMH), 49.0% people died through schizophrenia.

Increasing number of devices receiving regulatory approvals are anticipated to increase the market for new and advanced stimulators. For instance, in 2018, Brainsway received FDA approval for dTMS device for the treatment of Obsessive-Compulsive Disorder (OCD). In addition, increasing awareness programs by the various NGOs and associations will drive the market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/transcranial-magnetic-stimulator-market

Further key findings from the study suggest:

The Repetitive Transcranial Magnetic Stimulation System (rTMS) segment dominated the market in 2018. This is attributed to the increasing number of patients suffering from neurological disorders and Obsessive-Compulsive Disorder (OCD).
One of the major growing application is depression which is a mental disorder. TMS is considered appropriate therapy for the treatment of depression, mainly for those who have failed to achieve the satisfactorily treatment through antidepressant medication. According to WHO, in 2018, more than 300 million people are affected by the depression. It’s a leading cause of disability in the U.S population.
North America dominated the TMS market with the highest revenue share in 2018 owing to the increasing number of cases such as Alzheimer’s and Parkinson’s disease and increasing disposable income of individuals.
Some of the key players operating in the market are BrainsWay, MagStim, Nexstim, MagVenture and Eneura. Key players are introducing technologically enhanced products to gain a competitive advantage in the industry. For instance, in May 2019, MagStim received FDA approval for Horizon Stimguide TMS navigation system designed to provide precise and consistent coil positioning during treatment for major depressive disorders.

Uveitis Treatment Market Worth $765.31 Million By 2026

The global uveitis treatment market size is expected to reach USD 765.31 million by 2026, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 5.8% during the forecast period. Rising prevalence of the condition is anticipated to drive the growth. For instance, according to The Ocular Immunology and Uveitis Foundation, around 43,000 new eye inflammation cases are being diagnosed each year in U.S.

Eye inflammation is also very prevalent among children. However, majority of the affected population ranges from 20 to 50 years of age. Growing geriatric population is also an important factor driving the growth of the market. Rise in number of R&D activities aiming at new drug development is another attribute increasing the demand for these treatments.

For instance, ADX-102 Ophthalmic Solution, by Aldeyra Therapeutics, Inc. is in Phase 2 clinical trial for the treatment of noninfectious anterior uveitis. The National Eye Institute is also engaged in conducting and supporting various research studies in this field. Increasing prevalence of infectious diseases is another contributing factor to the market growth. Infectious uveitis surrounds a significant array of potential pathogens, which is likely to pose immense threat to the people affected.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/uveitis-treatment-market

Further key findings from the report suggest:

Corticosteroids led the market in 2018 owing to its wide application for treating noninfectious uveitis as well as availability of varied corticosteroids drugs
Monoclonal antibodies are expected to exhibit lucrative CAGR over the forecast period due to rising development of novel biologic drugs
Anterior held the largest market share in 2018 owing to growing prevalence and tendency of recurrence of anterior uveitis
Posterior is anticipated to showcase lucrative growth over the forecast period owing to rise in the number of R&D and clinical trials undergoing for the treatment posterior uveitis
Noninfectious segment held significant revenue share in 2018 owing to the wide array of treatment methods coupled with rising cases of the condition
Infectious segment is gaining traction in the uveitis treatment market owing to rising prevalence of infectious diseases
North America held the largest revenue share in 2018 owing to increasing prevalence of noninfectious uveitis as well as rising healthcare expenditure in this region
Asia Pacific is anticipated to exhibit lucrative CAGR over the forecast period due to the rising number of infectious diseases in the developing countries
Few major companies are Allergan, Inc.; Valeant Pharmaceutical International, Inc.; Eyegate Pharmaceuticals, Inc.; AbbVie Inc.; Regeneron Pharmaceuticals, Inc; and Santen Pharmaceutical Co., Ltd

Elastography Imaging Market Worth $3.5 Billion By 2026

The global elastography imaging market size is expected to reach USD 3.5 billion by the end of 2026, according to a new report by Grand View Research, Inc., registering a 7.8% CAGR over the forecast period. Increasing incidence of breast cancer and chronic liver disorders is expected to significantly drive the market. Additionally, increasing demand for minimally-invasive procedures and ongoing studies to assess the potential applications of elastography are factors expected to contribute toward rapid growth.

Currently elastography has wide applications in assessing breasts, thyroid, prostate, and liver. Increasing number of ongoing studies are expected to increase its applications in diagnosis of various conditions such neurodegenerative disorders and chronic kidney diseases. It has shown promising results for its use in assessment of kidney health during and after transplantation.

North America dominated the market in 2018 and is expected to continue its dominance during the forecast period. The elastography imaging market growth observed in the region is due to the presence of a large number of global players, along with high adoption rate for advanced imaging techniques.

Growing strategic alliances among players for development and distribution of products is expected to propel the market during the forecast period. Moreover, development of new surgical centers in different locations will increase the adoption of advanced imaging systems.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/elastography-imaging-market

Further key findings from the report suggest:

In 2018, non-cold chain logistics held the largest market share in terms of revenue owing to the sales of a large number of drugs that do not require any temperature control
Cold chain logistics segment is expected to register the faster CAGR over the forecast period owing to the demand for biologics, such as cellular therapies, vaccines, and test kits
Warehousing and storage held the largest market share among the types of services in 2018
Asia pacific expected to emerge with the fastest CAGR over the forecast period owing to adoption of medicines from aging population and shift of drug sales from brand manufacturers to generic
Key players operating in the biopharmaceutical third party logistics market include DHL International GmbH., SF Express, United Parcel Service of America, Inc, AmerisourceBergen Corporation, DB Schenker, Kuehne and Nagel, Kerry logistics network limited and AgilityBy modality, the ultrasound segment is predicted to register significant growth during the forecast period owing to advantages such as low price, accessibility, and high degree of measurement for tissue deformation
On the basis of end use, the hospital segment is anticipated to hold the largest share in the market during the forecast period due to rising number of ultrasound and MRI-based elastography procedures and growing trends of hospital-based imaging facilities
By way of application, the radiology domain is predicted to hold a large share in the market over the forecast period owing to increase in demand in image-guided radiotherapy and radiology ultrasound
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to improving healthcare facilities and rising geriatric population who are prone to developing targeted disorders
Major players in the elastography imaging industry are focusing on growth strategies such as partnerships, collaborations, mergers, and acquisitions. Some of the leading players are Esaote SpA; Canon Medical Systems Corporation; Koninklijke Philips N.V.; Hitachi, Ltd.; GE Healthcare; Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthineers; Toshiba America Medical Systems, Inc.; and Samsung Medison Co., Ltd.

Ophthalmic Knife Market Size Worth $2.4 Billion By 2026

The global ophthalmic knives market size is expected to reach USD 2.4 Billion by 2026, as per a new report by Grand View Research Inc. It is projected to register a CAGR of 4.9% during the forecast period. Introduction of advanced knives and rising incidence of age related ophthalmic diseases are some of the major factors driving the growth.

Increasing overall life expectancy and rising geriatric population is expected to cause steep increase in age related ophthalmic disorders. Along with these, incidence of lifestyle associated ophthalmic devices including myopia and hypermetropia are expected showcase significant growth during the forecast period. Most of these ophthalmic conditions cannot be treated by drugs. Increasing number of ophthalmic surgeries are expected to boost the market during forecast period.

High competition and introduction of local players are the factors encouraging market players to introduce advanced knives at affordable prices. Major players are focusing on developing innovative manufacturing techniques along with advanced raw materials to reduce the device price.

Incorporation of new reimbursement policies in developed countries along with growing efforts of non-profit organizations to increase awareness about ophthalmic conditions and to provide affordable/free ophthalmic procedures in rural regions are the factors expected to boost the number of ophthalmic surgeries.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/ophthalmic-knives-market

Further key findings from the report suggest:

North America captured the largest ophthalmic knife industry share in 2018 owing to favorable reimbursement policies, presence of major market players, and rise in geriatric population
Straight knives segment is anticipated to expand at a CAGR of 4.10% during the forecast period owing to fine design, durability, and sharpness of the knives
Slit knives segment is also expected to register lucrative CAGR in near future owing to extensive use for entry in anterior chamber/phaco stab incision (single bevel) in eye-related surgeries
Single-use/disposable knives segment is expected to witness significant growth over the forecast period due to features such as safety and affordability
The key players profiled in the ophthalmic knife market comprise Alcon, Inc.; Hoya Corporation; Essilor; Topcon Corporation; Hai Laboratories, Inc.; Bausch and Lomb Incorporated; MANI Inc.; Seiko Optical Products Co., Ltd.; Nidek Co., Ltd.; Ziemer Group; Alltion; and DGH Technology